Results 21 to 30 of about 943 (143)
Pachychoroid neovasculopathy in a male patient: a case report [PDF]
Pachychoroid neovasculopathy is a form of type 1 (subretinal pigment epithelium) neovascularization characterized by the involvement of dilated choroidal vessels in areas of increased choroidal thickness. This disease was originally described in three white female patients.
Miguel Hage, Amaro +1 more
core +7 more sources
Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy. [PDF]
Pachychoroid neovasculopathy (PNV) is treated with antivascular endothelial growth factor (VEGF) injection and photodynamic therapy (PDT), but no curative treatment has yet been established. We aimed to clarify the treatment results of a reduced dose of PDT for PNV. The subjects were 27 eyes of 27 patients (male:female = 20:7, mean age 58.9 years). PDT,
Tanaka K +5 more
europepmc +5 more sources
To report 3 cases of pachychoroid neovasculopathy, a form of Type 1 (sub-retinal pigment epithelium) neovascularization, occurring over areas of increased choroidal thickness and dilated choroidal vessels.A retrospective observational case series of three patients who underwent comprehensive ophthalmic examination and multimodal imaging with fundus ...
Claudine E, Pang, K Bailey, Freund
openaire +3 more sources
Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy. [PDF]
Abstract Background/Objectives. While the exact pathophysiology of pachychoroid disorders remains unclear, scleral changes inducing increased venous outflow resistance are hypothesized to be involved. This work aims to investigate anterior scleral thickness (AST) as a risk factor for central serous chorioretinopathy (CSC) and pachychoroid ...
Keidel LF +8 more
europepmc +4 more sources
Natural Course of Pachychoroid Pigment Epitheliopathy [PDF]
Purpose: To investigate the natural course of pachychoroid pigment epitheliopathy (PPE). Design: A retrospective cohort study. Subjects: From the Kyoto central serous chorioretinopathy (CSC) cohort consisting of 548 patients with CSC as of September 2020,
Mariko Yagi, MD +11 more
doaj +2 more sources
Validating the pachychoroid disease spectrum using multimodal imaging
Pachychoroid disease spectrum has garnered considerable interest and has been discussed in detail in recent literature. It refers to a group of retinal and choroidal disorders, namely pigment epitheliopathy, central serous chorioretinopathy ...
Guruprasad Ayachit +3 more
doaj +2 more sources
Background: The aim of this study was to compare optical coherence tomography angiography (OCTA) and indocyanine green angiography (ICGA) in detecting type-1 macular neovascularization (MNV) in pachychoroid spectrum diseases.
Sibel Demirel +4 more
doaj +2 more sources
Pachychoroid, an update from the new finding to the usual investigation in selected diseases
The authors make an update of pachychoroid in a group of the choroidal-retinal diseases that choroidal thickening is an usualenhanced depth image - optic coherence tomography (EDI-OCT) finding like as central serous chorioretinopathy, pachychoroid ...
Miguel Hage Amaro +4 more
doaj +2 more sources
This study aims to investigate the relationship between pachychoroid spectrum disorders and retinitis pigmentosa (RP) or rod-cone dystrophy through a comprehensive literature review.
Kasturi Chavan +3 more
doaj +2 more sources
Pachychoroid neovasculopathy (PNV) shares some anatomical features with other pachychoroid spectrum diseases, but little is known about the characteristics on the treatment with anti-vascular endothelial growth factor (VEGF).
Keiko Azuma +8 more
doaj +2 more sources

